JADAVPUR UNIVERSITY, INDIA
AUTHOR PROFILE
ORCID
EARLY ACADEMIC PURSUITS
Dr. Pallab Mandal’s academic journey demonstrates a rich multidisciplinary foundation in pharmaceutical sciences and life sciences. Beginning with a Bachelor of Science in Zoology, he transitioned into pharmaceutical studies with Diplomas in Pharmacy, Physiotherapy, and Medical Laboratory Technology, later advancing to a Bachelor and Master of Pharmacy at Jadavpur University. He is currently pursuing his Ph.D. in Pharmacology, reinforcing his commitment to scientific advancement and bioanalytical innovation.
PROFESSIONAL ENDEAVORS
With nearly a decade of experience, Dr. Mandal serves as the Head of Quality Assurance and Senior Bioanalyst (LC-MS/MS) at Taab BioStudy Services, a CDSCO-approved and GLP-accredited CRO. He leads laboratory operations, ensures compliance with GLP standards, and guides method development. His academic involvement as a faculty member at Jadavpur University’s Bioequivalence Study Centre highlights his dual role as both a researcher and educator.
CONTRIBUTIONS AND RESEARCH FOCUS IN PHARMACOLOGY
Dr. Mandal’s research centers around bioanalytical method development, pharmacokinetics, and therapeutic drug monitoring using LC-MS/MS and HPLC platforms. His notable pharmacology research includes:
-
Quantitative analysis of antihypertensive drug combinations,
-
Pharmacokinetic modeling of DPP-4 inhibitors,
-
Evaluation of anticancer potential of natural compounds like Triticum aestivum on MCF-7 breast cancer cell lines,
-
Collaborative international work on Diosmetin and Hesperitin.
ACCOLADES AND RECOGNITION
Dr. Mandal has earned a range of national and international recognitions:
-
M.N. Dev Memorial Award for academic excellence in D.Pharm.
-
IDMA Award 2018 for best research in pharmaceutical analysis.
-
INSO International Scientist Award (2022) for multidisciplinary contributions.
-
International ICON Award (2024) for excellence in pharmacological research.
He has also contributed book chapters in reputed pharmacology publications, expanding on drug mechanisms in hypertension, antibacterial therapy, and diuretic pharmacology.
IMPACT AND INFLUENCE
Dr. Mandal’s work contributes to bioequivalence studies, clinical pharmacology, and biomarker-based drug evaluations. His methodologies aid in improving drug efficacy evaluations, regulatory submissions, and healthcare analytics modeling. His conference participations and global presentations—most notably in USA, Malaysia, and India—have helped disseminate high-impact research in pharmacological sciences.
LEGACY AND FUTURE CONTRIBUTIONS
A recognized thought leader in bioanalytical pharmacology, Dr. Mandal’s future contributions are expected to delve deeper into cancer pharmacotherapy, drug metabolism studies, and data-driven pharmacokinetic modeling. His role in mentoring young researchers and advocating for regulatory-quality assurance in pharmacological studies promises to shape the next generation of clinical researchers.
NOTABLE PUBLICATIONS:
Title: An Audit on Design of Pharmaceutical Packaging
Authors: Pallab Mandal, Jasmina Khanam, Sanmoy Karmakar, Tapan Kumar Pal, Sujata Barma, Soumya Chakraborty, Rakesh Bera, Sourav Poddar
Journal: Journal of Packaging Technology and Research
Year: 2022
Title: Analytical Method Development and Validation of Trimethylazanium Containing Anti-leishmanial Phospholipid Drug Miltefosine by Liquid Chromatography Quadruple Tandem Mass Spectrometry (LC-ESI-MS/MS) API-2000
Authors: Pallab Mandal, Pradip Kundu, Soumya Chakraborty, Rakesh Bera, Nilendra Chatterjee, Sourav Poddar, D.P. Ghosh, Tapan Kumar Pal
Journal: Research Journal of Pharmacy and Technology
Year: 2022
Title: Anti-Hypertensive Activity of Some Selected Unani Formulations: An Evidence-Based Approach for Verification of Traditional Unani Claims Using LC-MS/MS for the Evaluation of Clinically Relevant Blood Parameters in Laboratory Rats
Authors: Pallab Mandal, Md. Adil Shaharyar, Rudranil Bhowmik, Obaid Afzal, Abdulmalik S. A. Altamimi, Sami I. Alzarea, Waleed Hassan Almalki, Sk Zeeshan Ali, Avishek Mandal et al.
Journal: Journal of Clinical Medicine
Year: 2022
Title: A Novel Validated Bio-Analytical Method Development for Azelnidipine (Dihydropyridine) in Indian Human Plasma by Liquid Chromatography Quadruple Tandem Mass Spectrometry (LC-ESI-MS/MS, API-4000) with an Application to In Vivo Pharmacokinetic and Bioequivalence Study
Authors: Pallab Mandal, Soumya Chakraborty, Rakesh Bera, Chiranjit Saha, Tapan K. Pal, Balaram Ghosh, Sourav Poddar
Journal: Indian Drugs
Year: 2022
Title: Internal Standard: An Important Analyte Used in Drug Analysis by Liquid Chromatography Mass Spectrometry – An Article
Authors: Pallab Mandal
Journal: International Journal of Pharmaceutical and Bio-Medical Science
Year: 2022
CONCLUSION
Dr. Pallab Mandal exemplifies excellence in bioanalytical research, pharmacological innovation, and academic mentorship. His combined experience in GLP-certified environments, his international exposure, and his scholarly rigor position him as a valuable contributor to global pharmaceutical sciences. His dedication to advancing analytical methodologies, drug safety evaluation, and clinical pharmacology research continues to influence both academia and industry.